Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
HMG-CoA reductase inhibitor
DRUG CLASS:
HMG-CoA reductase inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
ezetimibe/simvastatin (1)
lovastatin (0)
pitavastatin (0)
ezetimibe/simvastatin (1)
lovastatin (0)
pitavastatin (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS mutation
Colorectal Cancer
KRAS mutation
Colorectal Cancer
HMG-CoA reductase inhibitor + oxaliplatin
Sensitive: C2 – Inclusion Criteria
HMG-CoA reductase inhibitor + oxaliplatin
Sensitive
:
C2
HMG-CoA reductase inhibitor + oxaliplatin
Sensitive: C2 – Inclusion Criteria
HMG-CoA reductase inhibitor + oxaliplatin
Sensitive
:
C2
ACSL3 overexpression
Lung Non-Small Cell Squamous Cancer
ACSL3 overexpression
Lung Non-Small Cell Squamous Cancer
Sensitive: C3 – Early Trials
Sensitive
:
C3
Sensitive: C3 – Early Trials
Sensitive
:
C3
APC mutation
Colorectal Cancer
APC mutation
Colorectal Cancer
HMG-CoA reductase inhibitor
Sensitive: D – Preclinical
HMG-CoA reductase inhibitor
Sensitive
:
D
HMG-CoA reductase inhibitor
Sensitive: D – Preclinical
HMG-CoA reductase inhibitor
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login